Henry R. Appelbaum

Henry R. Appelbaum

Director Ejecutivo en Novian Health, Inc. .

Health Technology
Commercial Services
Consumer Services

Perfil

Henry R.
Appelbaum
is currently the President, Chief Executive Officer & Director at Novian Health, Inc. He is also a Business Advisor at iNetworks Advisors, Inc. Previously, he worked as an Associate Director - Marketing at Amgen, Inc. from 1989 to 1998.
He was a Principal at Argonne National Laboratory in 1989.
From 1998 to 2003, he served as the Vice President-Corporate Development at Source Precision Medicine, Inc. He was also a Principal at Battelle Corp.
from 1980 to 1987.
Mr. Appelbaum completed his undergraduate studies at the University of Rochester and his graduate studies at the Massachusetts Institute of Technology.
He received an MBA from The University of Chicago in 1989.

Cargos activos de Henry R. Appelbaum

EmpresasCargoInicio
Director Ejecutivo 01/02/2005
Consultor / Asesor -
Todos los cargos activos de Henry R. Appelbaum

Antiguos cargos conocidos de Henry R. Appelbaum.

EmpresasCargoFin
Corporate Officer/Principal 02/11/2003
AMGEN INC. Corporate Officer/Principal 02/10/1998
Corporate Officer/Principal 01/01/1989
Corporate Officer/Principal 01/01/1987
Ver el detalle de la experiencia de Henry R. Appelbaum.

Formación de Henry R. Appelbaum.

The University of Chicago Masters Business Admin
Massachusetts Institute of Technology Graduate Degree
Rochester Christian University Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Henry R. Appelbaum.

Relaciones

100 +

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
AMGEN INC.

Health Technology

Empresas privadas5

Health Technology

Health Technology

Commercial Services

Commercial Services

Finance

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Henry R. Appelbaum
-40% Prolongación excepcional: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA